Comments

Regeneron Pharmaceuticals

Q: What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

REGNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$710.00

-12.07-1.67%

At close: -

$709.53

-0.47-0.07%

After Hours: Feb 7, 7:21 PM EDT

The dividend Ex-Date is in 10 days

Q4 2024 Earnings were released on Tue Feb 4th, before the market open

The most recent conference call was at 8:30 AM, 6 days ago Click to view past webcast

Regeneron Pharmaceuticals (REGN) Forecast

News Earnings Regeneron Pharmaceuticals (REGN) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Quotes, Forecast and News Summary

Regeneron Pharmaceuticals Stock (NASDAQ: REGN) stock price, news, charts, stock research, profile.

Open	$726.46
Close	$710.00
Volume / Avg.	886.06K / 893.01K
Day Range	$709.55 - $731.42
52 Wk Range	642.00 - 1.21K
Market Cap	$77.97B
P/E Ratio	18.52
Dividend Yield	0.50%
Exchange	NASDAQ
RSI	48
Short Interest	2.03%
Days to Cover	2.54

Recent News

Billions in Buybacks: 4 Stocks Rewarding Shareholders Now

These four large-cap stocks recently announced buyback programs that are moderate to massive in size when compared to their market capitalizations. I’ll break down these new programs, as well as other important

MarketBeat

US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?

U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.

Piero Cingari

Regeneron Pharma Q4 Earnings Crush Estimates, Initiates Dividend And Additional Stock Buyback Program

Regeneron beat Q4 estimates with $12.07 EPS and $3.79B in sales. The company announced a dividend, a $3 billion buyback, and continued R&D investments.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$726.46
Close	$710.00
Volume / Avg.	886.06K / 893.01K
Day Range	$709.55 - $731.42
52 Wk Range	642.00 - 1.21K
Market Cap	$77.97B
P/E Ratio	18.52
Dividend Yield	0.50%
Exchange	NASDAQ
RSI	48
Short Interest	2.03%
Days to Cover	2.54

About Regeneron Pharmaceuticals, Inc.

Sector

Health Care

Industry

Biotechnology

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, c...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Regeneron Pharmaceuticals (REGN) stock?

You can purchase shares of Regeneron Pharmaceuticals (NASDAQ:REGN) through any online brokerage.

View our list of the best stock brokerages

Who are Regeneron Pharmaceuticals (REGN) competitors?

Other companies in Regeneron Pharmaceuticals’s space includes: BeiGene (NASDAQ:ONC), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for Regeneron Pharmaceuticals (REGN) stock?

Regeneron Pharmaceuticals has a consensus price target of $972.68.

What is the current price for Regeneron Pharmaceuticals (REGN)?

The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $709.5285 last updated February 7, 2025 at 7:21 PM EST.

Does Regeneron Pharmaceuticals (REGN) pay a dividend?

The next Regeneron Pharmaceuticals (REGN) dividend date is projected to be Thursday, February 20, 2025.

When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?

Regeneron Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Regeneron Pharmaceuticals (REGN) going to split?

There is no upcoming split for Regeneron Pharmaceuticals.

What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.